Identifying Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Laboratory Detection Methods for ESBL

ESBL-producing organisms are typically identified through antimicrobial susceptibility testing, with specific patterns of resistance to certain beta-lactam antibiotics, according to Praxis Medical Insights 1
The Clinical and Laboratory Standards Institute (CLSI) recommends routine ESBL testing is no longer necessary before reporting results when using the newer interpretive criteria for cephalosporins 2
MIC (Minimum Inhibitory Concentration) determination is another laboratory method used for ESBL detection, as stated by Praxis Medical Insights 1

The Clinical and Laboratory Standards Institute (CLSI) states that routine ESBL testing is no longer necessary before reporting results when using the newer interpretive criteria for cephalosporins 2
ESBL testing remains valuable for epidemiological and infection control purposes, according to the Journal of Microbiology, Immunology and Infection 2

Identification of ESBL-producing organisms is critical for appropriate antibiotic selection, as these infections are associated with higher mortality and complications if not properly treated, according to Praxis Medical Insights 1
The Journal of Infection recommends carbapenems as the treatment of choice for serious infections caused by ESBL-producing organisms 6
For patients with suspected ESBL infections, particularly in meningitis cases, meropenem 2g every 8 hours is recommended by the Journal of Infection 6

The new ceftazidime and cefepime susceptible breakpoints fail to identify many ESBL-producing E. coli, K. pneumoniae, and K. oxytoca, as reported by the Journal of Microbiology, Immunology and Infection 4
Automated susceptibility testing systems may have limitations in detecting ESBL-producing organisms using newer interpretive criteria, according to the Journal of Microbiology, Immunology and Infection 3